Sensyne Health : Interim Chief Financial Officer appointment

Regulatory Story
Go to market news section
Sensyne Health PLC - SENS Interim Chief Financial Officer appointment Released 17:29 02-Mar-2020

RNS Number : 7590E

Sensyne Health PLC

02 March 2020

Sensyne Health Appoints Interim Chief Financial Officer

Oxford, UK; 02 March 2020:Sensyne Health plc (LSE:SENS) ('Sensyne' or 'the Company'), the British Clinical AI technology company, today announces that it has appointed Michael Norris as Interim Chief Financial Officer, with immediate effect.

Michael has more than 20 years' experience working with public and private companies in the technology and life sciences sectors and has overseen a wide range of corporate activities. Michael has a wealth of CFO experience, serving as CFO and Interim CFO for a number of companies including Beckley Canopy Therapeutics, Itaconix, HMR and Rapid Rhythm. Michael is a Fellow of the Chartered Institute of Management Accountants.

A search for a permanent CFO is ongoing and the Company will update the market in due course.

-ENDS-

For more information please contact:

Sensyne Health (www.sensynehealth.com)	[phone]
Lord (Paul) Drayson, Chief Executive Officer
Peel Hunt LLP (Nominated Adviser and Joint Broker)	+ 44 (0) 20 7418 8900
Dr Christopher Golden
James Steel
Oliver Jackson
Liberum (Joint Broker)	+ 44 (0) 20 3100 2000
Bidhi Bhoma
Euan Brown
Consilium Strategic Communications	[phone]
Mary-Jane Elliott
Sukaina Virji
Melissa Gardiner
[e-mail]

About Sensyne Health

Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).

For more information, please visit: www.sensynehealth.com www.sensynehealth.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

BOAKKBBBOBKDQNK

Close

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2014London Stock Exchange plc. All rights reserved

Interim Chief Financial Officer appointment - RNS